Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly to offer single-dose vials of weight-loss drug
Eli Lilly Will Sell Zepbound Through Telehealth Company Ro in a Swipe at Legal Copycats
Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the branded drugs, Lilly on Wednesday said it would sell a version of Zepbound through the telemedicine company Ro.
Ro, Eli Lilly to streamline patient access to Zepbound single-dose vials
Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
By Sneha S K (Reuters) -Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity, becoming the first alternative platform for the lower-cost version of the drug to Lilly's own website.
24/7 Wall St
16h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 504.34% and ...
20h
on MSN
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline ...
STAT
18h
Eli Lilly to test obesity medications as treatments for alcohol and drug addiction, CEO says
Eli Lilly will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major ...
1d
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
Eli Lilly announces $15 billion share buyback plan and 15% dividend boost amidst mixed technical signals. Investors are ...
Senior Housing News
9h
Eli Lilly Partners with the Global Alzheimer’s Platform Foundation on Blood Test Study
Global Alzheimer's Platform Foundation (GAP) has partnered with Eli Lilly and Company (NYSE: LLY) for a study comparing blood ...
STAT
18h
Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s
Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.
1d
As Eli Lilly Shares Gain Over 35% YTD, Drugmaker Announces $15B Share Buyback Program And Boosts Dividend By 15%
According to the announcement, the share repurchase program allows for flexibility in purchasing methods, including open ...
2d
Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now
According to a sneak peek of the data from one of Eli Lilly's (NYSE: LLY) late-stage clinical trials, the cardiometabolic ...
5d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
20h
Eli Lilly announces results from the Phase 3 EMBER-3 study
Eli Lilly (LLY) and Company announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen ...
Ibj.com
5h
IEDC requests additional $60M for Lilly, Meta land, infrastructure at LEAP
The state's job-creation agency is seeking $27 million to purchase about 307 acres and pay for deposits and option payments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
India
Zepbound
Wisconsin
Trump
Novo Nordisk
Feedback